Skip to main content

Table 2 Suicide rates by anatomic site of cancer

From: Incidence of suicide among adolescent and young adult cancer patients: a population-based study

Sitea No of suicides No of patients Survival time (person-yeats) Overall(male and female) Male AYA patientse Female AYA patientse
Suicide ratebc SMRcd CIcd Suicide ratebc SMRcd CIcd Suicide ratebc SMRcd CIcd
Lung and bronchus 9 8029 34,610.2 22.79 1.90 0.986–3.651 35.28 1.69 0.759–3.762 15.34 2.53 0.815–7.835
Stomach 5 4294 12,559.5 37.12 2.97 1.234–7.124 65.01 2.28 0.736–7.079 20.5 5.38 1.344–21.495
Oral cavity and pharynx 25 7020 74,198.6 29.23 2.28 1.538–3.369 51.39 2.25 1.452–3.489 16.02 2.39 0.993–5.730
Hodgkin lymphoma 66 25,924 300,315.1 17.33 1.56 1.223–1.981 34.17 1.58 1.216–2.063 7.29 1.43 0.794–2.587
Kidney 9 8327 62,117.5 23.76 0.93 0.483–1.784 49.21 0.88 0.418–1.840 8.59 1.17 0.292–4.663
Thyroid 45 52,147 548,098.5 11.04 0.89 0.666–1.194 21.14 1.00 0.662–1.499 5.02 0.80 0.529–1.220
Nervous system 42 19,736 142,982.9 30 2.04 1.510–2.764 46.93 1.90 1.345–2.690 19.91 2.68 1.440–4.975
Non-hodgkin lymphoma 53 27,002 206,747.1 19.6 1.66 1.267–2.171 38.21 1.71 1.280–2.282 8.51 1.39 0.663–2.916
Leukemias 19 20,857 117,841.5 15.76 1.11 0.707–1.739 21.17 0.83 0.472–1.465 12.54 2.59 1.235–5.432
Colorectal 40 20,568 143,728.9 28.26 1.95 1.427–2.652 44.23 1.87 1.309–2.677 18.73 2.21 1.187–4.101
Bladder 17 4433 64,280.5 17.56 1.41 0.875–2.263 28.31 1.37 0.823–2.266 11.15 1.81 0.454–7.254
Nasopharyngeal carcinoma 6 1747 14,923.8 33.51 3.14 1.410–6.987 89.73 3.63 1.628–8.069 0 0.00
Gonad 9 6501 68,776.8 39 1.94 1.009–3.726 87.33 5.04 1.261–20.167 10.2 1.65 0.786–3.459
Breast 53 58,699 547,036.5        8.81 1.45 1.104–1.891
Cervix and uterus 43 29,976 341,688.2        12.02 1.95 1.447–2.630
Naso cav,mid ear,sinus,larynx 9 1417 13,479 55.91 4.00 2.083–7.692 54.62 3.11 1.395–6.912 56.68 9.49 3.060–29.410
Osseous and chondrommatous 17 6359 53,608 33.16 2.33 1.446–3.743 41.32 1.95 1.109–3.440 28.3 4.30 1.788–10.322
Soft tissue 87 26,070 188,201.8 34.2 3.06 2.479–3.773 72.81 3.24 2.595–4.044 11.18 2.06 1.072–3.959
Germ cell and trophoblastic 128 39,712 454,603 15.08 1.32 1.109–1.568 28.74 1.31 1.097–1.560 6.93 1.78 0.668–4.741
Melanoma and skin carcinomas 91 45,699 539,030.5 15.03 1.28 1.040–1.569 27.39 1.27 0.989–1.621 7.67 1.30 0.900–1.888
All AYA patients with single primary tumor 852 475,758 4,473,748.2 19.04 1.55 1.447–1.655 34.47 1.54 1.417–1.669 9.85 1.57 1.393–1.763
General US AYA population     12.31 1.00 Reference 22.42 1.00 Reference 6.28 1.00 Reference
  1. SMR standardized mortality ratio
  2. aAnalysis was limited to tumor sites for which at least 100,000 person years were accrued
  3. bPer 100,000 person-years
  4. cAdjusted to the age, race, and sex distributions of patients with a single primary tumor
  5. dReference population: general US AYA population, 1969 to 2015
  6. eSex-specific analysis, adjusted for age and race distributions of patients with single primary tumor